Align TechnologyALGNEarnings & Financial Report
Align Technology, Inc. is an American manufacturer of 3D digital scanners and Invisalign clear aligners used in orthodontics and restorative workflow. It was founded in 1997 and is headquartered in Tempe, Arizona. The company manufactures the aligners in Juarez, Mexico, and its scanners in Israel and China. The company is best known for its Invisalign system, which is a clear aligner treatment used to straighten teeth.
ALGN Q3 2025 Key Financial Metrics
Revenue
$995.7M
Gross Profit
$639.2M
Operating Profit
$96.3M
Net Profit
$56.8M
Gross Margin
64.2%
Operating Margin
9.7%
Net Margin
5.7%
YoY Growth
1.8%
EPS
$0.78
Financial Flow
Align Technology Q3 2025 Financial Summary
Align Technology reported revenue of $995.7M for Q3 2025, with a net profit of $56.8M (5.7% margin). Cost of goods sold was $356.5M, operating expenses totaled $542.9M.
Key Financial Metrics
| Total Revenue | $995.7M |
|---|---|
| Net Profit | $56.8M |
| Gross Margin | 64.2% |
| Operating Margin | 9.7% |
| Report Period | Q3 2025 |
Align Technology Annual Revenue by Year
Align Technology annual revenue history includes year-by-year totals (for example, 2024 revenue was $4.0B).
| Year | Annual Revenue |
|---|---|
| 2024 | $4.0B |
| 2023 | $3.9B |
| 2022 | $3.7B |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $956.7M | $997.4M | $1.03B | $977.9M | $995.2M | $979.3M | $1.01B | $995.7M |
| YoY Growth | 6.1% | 5.8% | 2.6% | 1.8% | 4.0% | -1.8% | -1.6% | 1.8% |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $6.08B | $6.16B | $6.16B | $6.37B | $6.21B | $6.10B | $6.22B | $6.23B |
| Liabilities | $2.45B | $2.40B | $2.40B | $2.42B | $2.36B | $2.31B | $2.31B | $2.28B |
| Equity | $3.63B | $3.76B | $3.76B | $3.94B | $3.85B | $3.79B | $3.91B | $3.96B |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $46.9M | $28.7M | $159.8M | $263.7M | $286.1M | $52.7M | $128.7M | $188.7M |
Other Health Care Companies
WST
West Pharmaceutical Services
Revenue
$805.0M
Net Profit
$132.1M
ABT
Abbott Laboratories
Revenue
$11.4B
Net Profit
$1.6B
ABBV
AbbVie
Revenue
$15.8B
Net Profit
$186.0M
A
Agilent Technologies
Revenue
$1.9B
Net Profit
$434.0M
AMGN
Amgen
Revenue
$9.9B
Net Profit
$1.3B
BAX
Baxter International
Revenue
$3.0B
Net Profit
$-1.1B
BDX
Becton Dickinson
Revenue
$5.3B
Net Profit
$382.0M
TECH
Bio-Techne
Revenue
$295.9M
Net Profit
$38.0M
BIIB
Biogen
Revenue
$2.3B
Net Profit
$-48.9M
BSX
Boston Scientific
Revenue
$5.3B
Net Profit
$670.0M